May 16, 2023 / 07:05PM GMT
Greg Renza - RBC Capital Markets - Analyst
Welcome back, everyone, to the 2023 RBC Global Healthcare Conference. My name is Greg Renza, one of the senior biotech equity research analysts here at RBC. And we're pleased to be joined by Pacira BioSciences.
Joining us from the company, of course, is the Chairman and CEO, Dave Stack, as well as the Chief Strategy Officer, Ron Ellis. Gentlemen, thanks for joining us.
Dave Stack - Pacira BioSciences, Inc. - CEO and Chairman
Thanks for the opportunity, Greg.
Questions and Answers:
Greg Renza - RBC Capital Markets - AnalystYeah. So why don't we dive right in? Certainly, a lot of interesting dynamics when it comes to the surgical environment with EXPAREL and the commercial drivers. But maybe, Dave, we can just have you take a step back and give us a brief overview of Pacira and just the current franchises in non-opioid pain relief.
Dave Stack - Pacira BioSciences, Inc. - CEO and Chairman
Yeah. Thank you, Greg. We